CD34+ Cell Dose Effects on Clinical Outcomes of Patients with Acute Myeloid Leukemia after T-Replete Haploidentical Allogeneic Hematopoietic Stemcell Transplantation Using Peripheral Blood Stem Cells. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini(Istituto di Ematologia di Bologna), Mohamad Mohty(Sorbonne Université), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Fabio Ciceri(Vita-Salute San Raffaele University), Patrice Chevallier(Hotel Dieu Hospital), Myriam Labopin(Sorbonne Université), Étienne Daguindau(Centre Hospitalier Universitaire de Besançon), Stéphanie Nguyen‐Quoc(Sorbonne Université), Mercedes Colorado(Marqués de Valdecilla University Hospital), Zafer Gülbaş, Arnon Nagler(Sheba Medical Center), Gèrard Socié(Hôpital Saint-Louis), Yener Koç(Antalya IVF), Didier Blaise(Institut Paoli-Calmettes)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k